The Corporation focussed on the biology of healing has had a busy November not only reporting Q3 results and highlights, and issuing improved financial guidance, but critically also agreeing amended terms with its long-term backers, thereby pushing out the maturity of its debt facilities (estimated at close to C$200m) to September 2024. The loans, ultimately controlled by Peter J. Thomson’s investment firm, Thomvest Asset Management include a C$100m facility that previously was due to e
21 Nov 2018
Steadying the ship
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Steadying the ship
ProMetic Life Sciences (PLI:TSE) | 0 0 1.3% | Mkt Cap: 1,075m
- Published:
21 Nov 2018 -
Author:
Derren Nathan -
Pages:
8
The Corporation focussed on the biology of healing has had a busy November not only reporting Q3 results and highlights, and issuing improved financial guidance, but critically also agreeing amended terms with its long-term backers, thereby pushing out the maturity of its debt facilities (estimated at close to C$200m) to September 2024. The loans, ultimately controlled by Peter J. Thomson’s investment firm, Thomvest Asset Management include a C$100m facility that previously was due to e